Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.54 USD | +3.46% | -1.54% | +4.98% |
04-25 | Transcript : Core Laboratories Inc., Q1 2024 Earnings Call, Apr 25, 2024 | |
04-24 | Earnings Flash (CLB) CORE LABORATORIES Reports Q1 Revenue $129.6M, vs. Street Est of $124.5M | MT |
Sales 2024 * | 538M 42.17B | Sales 2025 * | 579M 45.43B | Capitalization | 870M 68.19B |
---|---|---|---|---|---|
Net income 2024 * | 40M 3.14B | Net income 2025 * | 57M 4.47B | EV / Sales 2024 * | 1.86 x |
Net Debt 2024 * | 132M 10.35B | Net Debt 2025 * | 79M 6.19B | EV / Sales 2025 * | 1.64 x |
P/E ratio 2024 * |
22.2
x | P/E ratio 2025 * |
15.5
x | Employees | 3,500 |
Yield 2024 * |
0.22% | Yield 2025 * |
0.22% | Free-Float | 98.96% |
Latest transcript on Core Laboratories Inc.
1 day | +3.46% | ||
1 week | -1.54% | ||
Current month | +17.34% | ||
1 month | +9.45% | ||
3 months | +25.19% | ||
6 months | +2.94% | ||
Current year | +4.98% |
Managers | Title | Age | Since |
---|---|---|---|
Lawrence Bruno
CEO | Chief Executive Officer | 64 | - |
Christopher Hill
DFI | Director of Finance/CFO | 54 | - |
Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Curtis Anastasio
BRD | Director/Board Member | 67 | 27/06/23 |
Director/Board Member | 71 | 31/12/19 | |
Director/Board Member | 74 | 31/12/15 |
Date | Price | Change | Volume |
---|---|---|---|
28/05/24 | 18.54 | +3.46% | 256,081 |
24/05/24 | 17.92 | -1.16% | 278,050 |
23/05/24 | 18.13 | -1.57% | 303,684 |
22/05/24 | 18.42 | -2.18% | 368,165 |
21/05/24 | 18.83 | +2.73% | 341,501 |
Delayed Quote Nyse, May 28, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.98% | 870M | |
-18.94% | 2.66B | |
-15.28% | 2.59B | |
-29.53% | 1.78B | |
0.00% | 1.35B | |
-11.73% | 1.05B | |
-9.70% | 1.03B | |
-18.57% | 759M | |
-2.49% | 743M | |
-27.60% | 644M |
- Stock Market
- Equities
- CLB Stock